About Michael Cardone
Form D filings for Eutropics Pharmaceuticals from 2021 to 2024 list Michael Cardone as CEO and director.
Michael Cardone first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Cardone in the role, so the role may have started earlier or lasted longer.